List view / Grid view
21 August 2015 | By Dolomite
Dolomite, a world leader in microfluidics innovation, has launched new flexible, cost-effective Flow Chemistry Systems at the 250th American Chemical Society Meeting and Exposition in August 2015...
21 August 2015 | By Victoria White
The EMA has validated for review a MAA for Ibrance in combination with endocrine therapy for the treatment of HR+/HER2- metastatic breast cancer...
21 August 2015 | By Victoria White
Takeda has announced that the EMA has accepted is Marketing Authorisation Application for ixazomib for the treatment of patients with multiple myeloma...
20 August 2015 | By Victoria White
The EC has approved Novartis’ Odomzo (sonidegib) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma...
20 August 2015 | By Victoria White
The global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, says GBI Research...
20 August 2015 | By Victoria White
Valeant has entered into a definitive agreement to acquire Sprout, makers of female libido drug Addyi, for approximately $1 billion...
20 August 2015 | By Victoria White
Boehringer Ingelheim and Lilly have announced positive top-line results from a clinical study investigating cardiovascular (CV) outcomes for Jardiance...
20 August 2015 | By Victoria White
Vernalis has announced results from a Phase II proof-of-concept study of V158866, its fatty acid amide hydrolase (FAAH) inhibitor...
19 August 2015 | By Victoria White
Alexion, Regeneron,Incyte and BioMarin have all been ranked in the top ten on Forbes magazine's 2015 list of the "World's Most Innovative Companies"...
19 August 2015 | By Victoria White
NIAID has provided Soligenix an additional $2.7 million in funding to advance the development of its heat stabilised ricin toxin vaccine, RiVax...
19 August 2015 | By Victoria White
Kuros, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products, has closed a financing round of CHF15M...
19 August 2015 | By
The US FDA has approved Sprout’s Addyi (flibanserin) to treat acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women...
18 August 2015 | By Victoria White
Bavarian Nordic has initiated a Phase 1 clinical study of its MVA-BN vaccine candidate against respiratory syncytial virus (RSV)...
The global market for growth hormone deficiency (GHD) treatment will rise in value from $1.26 billion in 2014 to reach approximately $1.88 billion by 2024, representing a moderate Compound Annual Growth Rate (CAGR) of 4.08%, according to research and consulting firm GlobalData.
18 August 2015 | By Victoria White
An international study of people with a family history of cancer has shown that a regular dose of aspirin reduces the long-term risk of the disease...
